The "Iuliu Haţieganu" University of Medicine and Pharmacy in Cluj-Napoca is participating in the development of a European master's program that will combine medicine, neuroscience, artificial intelligence, and engineering. Scheduled to begin in the 2027-2028 academic year, the program will train specialists in brain-applied technologies and the use of artificial intelligence for neurological research. According to UMF Cluj, the "European Master in Neurotechnology" (EMN) will cover areas such as brain-computer interfaces, the analysis of neural data, and the application of artificial intelligence in brain research. The program is being developed within the framework of the NeurotechEU university alliance, of which the Cluj-based university is a founding member. Academic institutions from the Netherlands, Spain, Germany, Turkey, France, and Iceland are also participating in the project.
• Brain-computer interfaces and artificial intelligence in neurological research
The program will also address medical applications of neurotechnology, including the diagnosis, treatment, and rehabilitation of patients with neurological conditions. UMF "Iuliu Haţieganu" will contribute to two components of the master's program-Clinical and Technology-leveraging its expertise in clinical research and the integration of modern technologies into medicine.
The university's Rector, Anca Dana Buzoianu, believes that participation in this project reflects the evolution of medicine toward increasingly close interdisciplinary collaboration and a broader integration of technology. "Our university's involvement in this joint master's program also entails taking on an active role in the development of new European educational models, in which universities pool their expertise, resources, and capacity for innovation," stated the rector.
• Two years of study and a joint degree
The European Master in Neurotechnology will span two years and be taught in English. Students will have the opportunity to study and conduct research at the partner universities. International mobility will be mandatory during the third semester, and upon completion of the program, graduates will receive a joint degree issued by the seven participating universities. The master's program is aimed at candidates with a relevant academic background, including those from outside the partner universities or from outside Europe. Through its participation in this project, UMF Cluj strengthens its engagement in international academic collaborations within the field of neurotechnology, with prospects for the advancement of medical education and interdisciplinary research.
























































